Intelliseq
Intelliseq turns raw NGS data into clinical reports to speed diagnostics and lower analysis costs. It does this via a cloud-based platform of automated, modular bioinformatics pipelines that use AI-based algorithms and prebuilt workflows for pharmacogenomics, germline disorders, somatic cancer, and polygenic risk scoring. The platform includes reproducible pipelines, customizable workflows, and APIs to integrate with laboratory information systems and ensure regulatory readiness. Intelliseq operates as a B2B SaaS serving diagnostic laboratories, biopharma companies, and research institutions. The company supports large-scale processing to enable simultaneous thousands of analyses and has customers across Asia, Europe, and the US.
Intelliseq
Intelliseq turns raw NGS data into clinical reports to speed diagnostics and lower analysis costs. It does this via a cloud-based platform of automated, modular bioinformatics pipelines that use AI-based algorithms and prebuilt workflows for pharmacogenomics, germline disorders, somatic cancer, and polygenic risk scoring. The platform includes reproducible pipelines, customizable workflows, and APIs to integrate with laboratory information systems and ensure regulatory readiness. Intelliseq operates as a B2B SaaS serving diagnostic laboratories, biopharma companies, and research institutions. The company supports large-scale processing to enable simultaneous thousands of analyses and has customers across Asia, Europe, and the US.